TY - JOUR
T1 - Speckle tracking echocardiography in primary mitral regurgitation
T2 - should we reconsider the time for intervention?
AU - Pastore, Maria Concetta
AU - Mandoli, Giulia Elena
AU - Dokollari, Aleksander
AU - Bisleri, Gianluigi
AU - D’Ascenzi, Flavio
AU - Santoro, Ciro
AU - Miglioranza, Marcelo Haertel
AU - Focardi, Marta
AU - Cavigli, Luna
AU - Patti, Giuseppe
AU - Valente, Serafina
AU - Mondillo, Sergio
AU - Cameli, Matteo
N1 - Publisher Copyright:
© 2021, The Author(s).
PY - 2022/7
Y1 - 2022/7
N2 - Thanks to the improvement in mitral regurgitation (MR) diagnostic and therapeutic management, with the introduction of minimally invasive techniques which have considerably reduced the individual surgical risk, the optimization of the timing for MR “open” or percutaneous surgical treatment has become a main concern which has highly raised scientific interest. In fact, the current indications for intervention in MR, especially in asymptomatic patients, rely on echocardiographic criteria with high severity cut-offs that are fulfilled only when not only mitral valve apparatus but also the cardiac chambers’ structure and function are severely impaired, which results in poor benefits for post-operative clinical outcome. This led to the need of new indices to redefine the optimal surgical timing in these patients. Speckle tracking echocardiography provides early markers of cardiac dysfunction due to subtle myocardial impairment; therefore, it could offer pivotal information in this setting. In fact, left ventricular and left atrial strains have already shown evidence about their usefulness in recognizing MR impact not only on symptoms and quality of life but also on cardiovascular events and new-onset atrial fibrillation in these patients. Moreover, right ventricular strain could be used to identify those patients with advanced cardiac damage and different grades of right ventricular dysfunction, which entails higher risks for cardiac surgery that could overweigh surgical benefits. This review aims to describe the importance of reconsidering the timing of intervention in MR and to analyze the potential additive value of speckle tracking echocardiography in this clinical setting.
AB - Thanks to the improvement in mitral regurgitation (MR) diagnostic and therapeutic management, with the introduction of minimally invasive techniques which have considerably reduced the individual surgical risk, the optimization of the timing for MR “open” or percutaneous surgical treatment has become a main concern which has highly raised scientific interest. In fact, the current indications for intervention in MR, especially in asymptomatic patients, rely on echocardiographic criteria with high severity cut-offs that are fulfilled only when not only mitral valve apparatus but also the cardiac chambers’ structure and function are severely impaired, which results in poor benefits for post-operative clinical outcome. This led to the need of new indices to redefine the optimal surgical timing in these patients. Speckle tracking echocardiography provides early markers of cardiac dysfunction due to subtle myocardial impairment; therefore, it could offer pivotal information in this setting. In fact, left ventricular and left atrial strains have already shown evidence about their usefulness in recognizing MR impact not only on symptoms and quality of life but also on cardiovascular events and new-onset atrial fibrillation in these patients. Moreover, right ventricular strain could be used to identify those patients with advanced cardiac damage and different grades of right ventricular dysfunction, which entails higher risks for cardiac surgery that could overweigh surgical benefits. This review aims to describe the importance of reconsidering the timing of intervention in MR and to analyze the potential additive value of speckle tracking echocardiography in this clinical setting.
KW - Echocardiography
KW - Mitral regurgitation
KW - Speckle tracking
KW - Surgery
KW - Timing
KW - Treatment
UR - https://www.scopus.com/pages/publications/85103905371
U2 - 10.1007/s10741-021-10100-1
DO - 10.1007/s10741-021-10100-1
M3 - Review article
SN - 1382-4147
VL - 27
SP - 1247
EP - 1260
JO - Heart Failure Reviews
JF - Heart Failure Reviews
IS - 4
ER -